A detailed history of Brown Brothers Harriman & CO transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 67 shares of DGX stock, worth $9,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67
Previous 26 157.69%
Holding current value
$9,185
Previous $3,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$137.09 - $137.09 $5,620 - $5,620
41 Added 157.69%
67 $9,000
Q4 2023

Feb 12, 2024

SELL
$120.62 - $141.12 $250,648 - $293,247
-2,078 Reduced 98.76%
26 $3,000
Q3 2023

Nov 13, 2023

BUY
$121.86 - $144.92 $249,934 - $297,230
2,051 Added 3869.81%
2,104 $256,000
Q2 2023

Aug 07, 2023

SELL
$130.56 - $146.84 $1,566 - $1,762
-12 Reduced 18.46%
53 $7,000
Q1 2023

May 11, 2023

SELL
$131.53 - $155.76 $32,224 - $38,161
-245 Reduced 79.03%
65 $9,000
Q4 2022

Feb 09, 2023

BUY
$123.31 - $157.26 $29,224 - $37,270
237 Added 324.66%
310 $48,000
Q3 2022

Nov 10, 2022

SELL
$121.77 - $141.1 $1,339 - $1,552
-11 Reduced 13.1%
73 $9,000
Q2 2022

Aug 11, 2022

SELL
$127.07 - $145.39 $83,866 - $95,957
-660 Reduced 88.71%
84 $11,000
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $85,070 - $108,306
659 Added 775.29%
744 $102,000
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $4,786 - $5,688
36 Added 73.47%
85 $12,000
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $24,952 - $27,871
-197 Reduced 80.08%
49 $6,000
Q1 2021

May 13, 2021

SELL
$114.63 - $133.34 $75,885 - $88,271
-662 Reduced 72.91%
246 $32,000
Q4 2020

Feb 16, 2021

BUY
$112.7 - $128.05 $28,400 - $32,268
252 Added 38.41%
908 $108,000
Q3 2020

Nov 16, 2020

SELL
$107.05 - $130.01 $13,488 - $16,381
-126 Reduced 16.11%
656 $75,000
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $56,985 - $95,267
777 Added 15540.0%
782 $89,000
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $1,051 - $1,619
-14 Reduced 73.68%
5 $0
Q4 2019

Feb 14, 2020

SELL
$100.29 - $107.99 $1,704 - $1,835
-17 Reduced 47.22%
19 $2,000
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $1,859 - $2,040
19 Added 111.76%
36 $4,000
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $1,788 - $2,140
-21 Reduced 55.26%
17 $2,000
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $1,129 - $1,258
-14 Reduced 26.92%
38 $3,000
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $5,481 - $5,979
52 New
52 $6,000
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $19,380 - $21,683
-201 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $2,271 - $2,506
25 Added 14.2%
201 $20,000
Q2 2017

Aug 14, 2017

BUY
N/A
176
176 $20,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.